Pasireotide
Drug timelines are a Plus or Pro feature.
26 regulatory and trial events tracked for Pasireotide, covering 2013-02-06 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study